carboplatin,nivolumab,paclitaxel
bms
['nsclc', 'nadim i,(-nadim ii)', 'sclc']
#esmo22 poster session: changes in immune gene signatures after neoadjuvant chemoimmunotherapy treatment in nsclc patients from nadim i trial marta casarrubios changes immune expression observed in patients with pcr tumors reflecting an active immune response 
GECP/SLCG
Desde 1991 investigando para avanzar en curación y supervivencia al #cancerdepulmon 
#LungResearch #GECPResearch #CancerResearch